Fair Value Measurements & Derivative Instruments (Details Textual) (USD $)	1 Months Ended	9 Months Ended		1 Months Ended	9 Months Ended			9 Months Ended
	Jan. 31, 2011	Jun. 30, 2012	Jun. 17, 2010	Jan. 31, 2011 Unidym, Inc [Member]	Jun. 30, 2012 Unidym, Inc [Member]	Sep. 30, 2011 Unidym, Inc [Member]	Jun. 30, 2011 Unidym, Inc [Member]	Jun. 30, 2012 Ablaris Therapeutics, Inc [Member]
Fair Value Measurements & Derivative Instruments (Textual) [Abstract]
Non cash consideration received in sale of interest in subsidiary, bonds	$ 2,500,000			$ 2,500,000
Bond convertible conversion price				$ 2.00
Derivative fair value related to third party					13,282	6,854	26,310
Gain from change in value of the derivative asset, net of the derivative liability					144,697
Gain from change in value of the derivative asset		151,125			151,125
Warrants issued to acquire common stock			329,649
Non cash gain (loss) from change in fair value of derivative liability		$ (74,330)						$ 7,312
Exchange right convertible conversion ratio for first year								0.0006
Exchange right convertible conversion ratio for two year								0.0004
Exchange right convertible conversion ratio for three year								0.0003
Exchange right convertible conversion ratio for four year								0.0002
Exchange right convertible conversion ratio for five year								0.0001
Number of shares sold, acquired by way of of conversion of bond								675,000
Duration of bond		7 years